Three‐year Follow‐up Results From Phase II Studies of Nivolumab in Japanese Patients With Previously Treated Advanced Non‐small Cell Lung Cancer: Pooled Analysis of ONO‐4538‐05 and ONO‐4538‐06 Studies

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2411
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

638PTwo Year Survival and Safety Update for Esophageal Squamous Cell Carcinoma Treated With Nivolumab (ATTRACTION-01/ONO-4538-07)

Annals of Oncology
MedicineOncologyHematology
2017English

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2015English

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

A Phase I Trial and in Vitro Studies Combining ABT-751 With Carboplatin in Previously Treated Non-Small Cell Lung Cancer Patients

Chemotherapy
MedicineDrug DiscoveryInfectious DiseasesOncologyPharmacology
2012English

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

JAMA Oncology
Cancer ResearchOncology
2019English

179P: Nivolumab Monotherapy in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice in a Spanish Center

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy